Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome
Abstract
Hypogammaglobulinemia is a major adverse event after rituximab treatment; however, the precise incidence and risk factors are unclear in complicated steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS) patients.This was a single-center, retrospective, observational study. Patients who received a single dose of rituximab for complicated SDNS or FRNS between February 2007 and May 2019 were enrolled. Serum IgG levels were...
Paper Details
Title
Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome
Published Date
Oct 4, 2021
Journal
Volume
37
Issue
5
Pages
1057 - 1066
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History